Nov 17, 2021 / 10:30PM GMT
Presentation (Japanese)
Nov 17, 2021 / 10:30PM GMT
=====================
Corporate Participants
=====================
* Adrian Murphy
Shire plc - Senior VP & Head of Plasma Operations
* Dana Mendenhall
* Elizabeth Borgeson
Takeda Pharmaceutical Company Limited - Executive of IR
* Hema Tallman
* Julie Kim
Takeda Pharmaceutical Company Limited - President of Plasma-Derived Therapies Business Unit
* Kristina Allikmets
* Ramy Riad
=====================
Conference Call Participants
=====================
* Akinori Ueda
Goldman Sachs Group, Inc., Research Division - Equity Analyst
* Andrew Goodsall
* Fumiyoshi Sakai
Crédit Suisse AG, Research Division - Research Analyst
* Hidemaru Yamaguchi
Citigroup Inc. Exchange Research - Research Analyst
* Kazuaki Hashiguchi
Daiwa Securities Co. Ltd., Research Division - Research Analyst
* Seiji Wakao
JPMorgan Chase & Co, Research Division - VP
* Shinichiro Muraoka
Takeda Pharmaceutical Co Ltd
(OTCPK:TKPHF)
$
28.6
0 (0%)
Market Cap: 44.77 Bil
Enterprise Value: 71.99 Bil
PE Ratio: 23.21
PB Ratio: 0.98
GF Score: 78/100 Takeda Pharmaceutical Co Ltd Plasma-Derived Therapies Investor Event Presentation (Japanese) Transcript
Nov 17, 2021 / 10:30PM GMT
Release Date Price:
$27.85
(-2.10%)
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot